Ian Karp
Public Communications Contact bei INTELLIA THERAPEUTICS, INC.
Profil
Ian Karp is currently the Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. He previously worked as the Senior Director-Global Marketing at Medimmune, Inc. and as the Vice President & Head-Investor Relations at Shire Plc.
He also served as the Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc. Mr. Karp received his undergraduate degree from Emory University and his MBA from Rutgers Business School.
Aktive Positionen von Ian Karp
| Unternehmen | Position | Beginn |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - |
Ehemalige bekannte Positionen von Ian Karp
| Unternehmen | Position | Ende |
|---|---|---|
| SHIRE | Investor Relations Contact | 01.12.2017 |
| Medimmune, Inc. | Sales & Marketing | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | - |
Ausbildung von Ian Karp
| Emory University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Medimmune, Inc. | Health Technology |
